CACNB3 Protein (Voltage-Gated Calcium Channel Beta-3 Subunit)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CACNB3 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Voltage-gated calcium channel subunit beta 3</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>CACNB3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P54284</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~66 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>VGCC β subunit family (SH3-GUK domain structure)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/mesial-temporal-lobe-epilepsy" style="color:#ef9a9a">Mesial Temporal Lobe Epilepsy</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
Overview
The CACNB3 protein (Calcium Voltage-Gated Channel Auxiliary Subunit Beta 3) is an auxiliary β subunit of voltage-gated calcium channels (VGCCs). These auxiliary subunits play critical roles in modulating calcium channel trafficking, gating properties, and current kinetics. In the brain, CACNB3 is expressed in various neuronal populations where it contributes to calcium signaling pathways essential for neuronal excitability, synaptic transmission, and gene expression. [@ertel2000]
Introduction
...CACNB3 Protein (Voltage-Gated Calcium Channel Beta-3 Subunit)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CACNB3 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Voltage-gated calcium channel subunit beta 3</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>CACNB3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P54284</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~66 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>VGCC β subunit family (SH3-GUK domain structure)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/mesial-temporal-lobe-epilepsy" style="color:#ef9a9a">Mesial Temporal Lobe Epilepsy</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
Overview
The CACNB3 protein (Calcium Voltage-Gated Channel Auxiliary Subunit Beta 3) is an auxiliary β subunit of voltage-gated calcium channels (VGCCs). These auxiliary subunits play critical roles in modulating calcium channel trafficking, gating properties, and current kinetics. In the brain, CACNB3 is expressed in various neuronal populations where it contributes to calcium signaling pathways essential for neuronal excitability, synaptic transmission, and gene expression. [@ertel2000]
Introduction
Voltage-gated calcium channels are essential for converting electrical signals into biochemical responses in excitable cells. The channels consist of a main α1 subunit that forms the pore, along with auxiliary α2δ and β subunits that modulate channel function. The β subunits (CACNB1-4) are cytosolic proteins that bind to the α1 subunit via a high-affinity interaction with the AID (α-interacting domain) motif, fundamentally altering channel behavior. [@abernethy2002]
CACNB3 is one of four β subunit isoforms in mammals and is prominently expressed in the nervous system, particularly in regions involved in cognitive function and motor control. [@altier2007]
Structure
Protein Architecture
Domain Organization
The CACNB3 protein contains several distinct structural domains:
SH3 Domain (Src Homology 3) — Located at the N-terminus, this domain is involved in protein-protein interactions with signaling molecules containing proline-rich motifs.
Guanylate Kinase (GUK) Domain — The core of the protein, this domain mediates the high-affinity interaction with the α1 subunit of VGCCs. The GUK domain contains the AID-binding pocket that recognizes the AID motif on the α1 subunit.
N-terminal Variable Region — Contains isoform-specific sequences that contribute to differential interactions with various α1 subunits.The β subunit lacks transmembrane segments and is entirely cytosolic, anchoring to the membrane via its interaction with the α1 subunit.
Function
Channel Modulation
CACNB3 modulates voltage-gated calcium channels through several mechanisms:
Trafficking — β subunits are essential for proper localization of VGCCs to the plasma membrane. They facilitate the assembly and export of the channel complex from the endoplasmic reticulum.
Gating Modification — Binding of CACNB3 shifts the voltage-dependence of activation and inactivation, altering the voltage range at which channels open.
Current Kinetics — β subunits modulate the rate of activation and inactivation, influencing the shape of calcium currents.
Channel Density — By promoting surface expression, β subunits increase the density of functional channels at the plasma membrane.Specific VGCC Types
CACNB3 preferentially associates with Cav1.2 (L-type) and Cav2.2 (N-type) channels, as well as certain Cav3 (T-type) channels. The specific combination of α1 and β subunits determines the biophysical properties of the channel complex.
Expression Pattern
In the brain, CACNB3 is expressed in:
- Cerebral [cortex](/brain-regions/cortex) (pyramidal neurons)
- [Hippocampus](/brain-regions/hippocampus) (CA1-CA3 regions, dentate gyrus)
- Cerebellum (Purkinje cells, granule cells)
- Basal ganglia
- Thalamus
- Brainstem nuclei
This widespread expression reflects the diverse roles of VGCCs in neuronal signaling throughout the central nervous system.
Role in Neurodegeneration
Calcium Dysregulation
Calcium dysregulation is a hallmark of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD). Altered expression or function of calcium channel subunits, including CACNB3, may contribute to:
Excitotoxicity — Impaired calcium homeostasis can lead to excessive calcium influx, triggering apoptotic pathways.
Synaptic Dysfunction — Calcium channels are essential for synaptic transmission; alterations affect neurotransmitter release and plasticity.
Mitochondrial Dysfunction — Calcium overload can impair mitochondrial function, increasing oxidative stress.Alzheimer's Disease
In Alzheimer's disease, alterations in L-type calcium channels (Cav1.2) have been implicated in [amyloid-beta](/proteins/amyloid-beta) toxicity. CACNB3, as an auxiliary subunit of these channels, may modulate susceptibility to amyloid-induced neuronal damage. Studies have shown that β subunit expression can influence the vulnerability of [neurons](/entities/neurons) to calcium-mediated [apoptosis](/entities/apoptosis).
Parkinson's Disease
Voltage-gated calcium channels, particularly Cav1.3 (L-type) and Cav2.1 (P/Q-type), play roles in dopaminergic neuron survival. CACNB3 may contribute to the calcium handling properties of these neurons, which are particularly vulnerable in PD.
Therapeutic Implications
Modulating CACNB3 function represents a potential therapeutic strategy:
- Channel-Specific Targeting — Different β subunit isoforms confer distinct properties; targeting specific combinations may provide selectivity.
- Allosteric Modulation — Compounds that modulate β subunit-α1 interactions could fine-tune calcium channel function.
Interactions
CACNB3 interacts with:
- VGCC α1 subunits (Cav1.2, Cav2.2, Cav3.x)
- AKAP150/AKAP5 (A-kinase anchoring protein)
- Receptor for activated C kinase 1 (RACK1)
- Various signaling proteins via SH3 domain
- Knockout Mice — Cacnb3 knockout mice have been generated and show alterations in calcium channel function
- siRNA/shRNA — Used to knockdown CACNB3 expression in cell culture
- Peptide toxins — ω-conotoxins and other toxins can distinguish between channels with different β subunits
See Also
- Calcium Channels Overview
- [Voltage-Gated Ion Channels](/mechanisms/ion-channel-dysfunction)
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Neurodegeneration Mechanisms](/content/mechanisms)
External Links
- [NCBI Gene - CACNB3](https://www.ncbi.nlm.nih.gov/gene/783)
- [UniProt - CACNB3 (P54284)](https://www.uniprot.org/uniprot/P54284)
- [IUPHAR/BPS Guide to Pharmacology - CaV beta subunits](https://www.guidetopharmacology.org/GRID/FamilyView?familyId=54)
References
[Ertel EA, Campbell KP, Harpold MM, et al, Nomenclature of voltage-gated calcium channels (2000)](https://pubmed.ncbi.nlm.nih.gov/10717922/))
[Abernethy DR, Soldatov NM, Structure-functional diversity of human L-type Ca2+ channel: perspectives for novel pharmacological approaches (2002)](https://pubmed.ncbi.nlm.nih.gov/11951536/))
[Altier C, Khosravani H, Evans RM, et al, ORL1 receptor-mediated calcium signaling in the pathogenesis of neurodegeneration (2007)](https://pubmed.ncbi.nlm.nih.gov/17350696/))
[Bezprozvanny I, Calcium signaling and neurodegenerative diseases (2009)](https://pubmed.ncbi.nlm.nih.gov/19230771/))
[Striessnig J, Pinggera A, Kaur G, Bock G, Tuluc P, L-type Ca2+ channels in CNS neurons: molecular regulation, physiology, and pathophysiological implications (2014)](https://pubmed.ncbi.nlm.nih.gov/24969039/))
[Hofmann F, Lacinová L, Klugbauer N, Voltage-dependent calcium channels: from structure to function (1999)](https://pubmed.ncbi.nlm.nih.gov/10543552/))
[Dolphin AC, Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond (2012)](https://pubmed.ncbi.nlm.nih.gov/22814511/))
[Green PJ, Warrier S, Vijayakumar S, et al, The role of voltage-gated calcium channel genes in age-related macular degeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/36456576/))